Epilepsy & Seizures

• CBD for children with Dravet’s and intractable seizures (Video)
• Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy (PubMed)
• Medicinal marijuana stops seizures, brings hope to a little girl (Gazette, Colorado Springs)
• Cannabinoids for epilepsy (PubMed)
• Cannabis, cannabidiol, and epilepsy – From receptors to clinical response (PubMed)
• The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability (ACS Publications)
• Chronic administration of cannabidiol to healthy volunteers and epileptic patients (PubMed)
• Endocannabinoid system protects against cryptogenic seizures (PubMed)
• Seizing an opportunity for the endocannabinoid system (Pub Med)
• Cannabidiol: promise and pitfalls (Pub Med)
• Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatricdisorders (PubMed)
• Report of a parent survey of cannabidiol-enriched cannabis use in pediatrictreatment-resistant epilepsy (Epilepsy Association of Utah)
• From the Editors: Cannabidiol and medical marijuana for the treatment of epilepsy (PubMed)
• Cannabidivarin (CBDV) suppressespentylenetetrazole (PTZ)-inducedincreases in epilepsy-related gene expression (PubMed)
• Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures(PubMed)
• Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo (PubMed)
• Hypnotic and antiepileptic effects of cannabidiol (PubMed)
• The cannabinoids as potential antiepileptics (PubMed)
• Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats (PubMed)
• Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus (The American Society for Pharmacology and Experimental Therapeutics)
• Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (Pharmacology Research and Perspectives)
• Assessment of the role of CB receptors in cannabinoid 1 anticonvulsant effects (European Journal of Pharmacology)
• Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo (The American Society for Pharmacology and Experimental Therapeutics)
• Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures (ScienceDirect)
• Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (Department of Neurology, Comprehensive Epilepsy Center)
• Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (Mediators of Inflammation)
• Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression (School of Chemistry, Food and Nutritional Sciences and Pharmacy, The University of Reading, Berkshire, UK)
• Cannabidivarin is anticonvulsant in mouse and rat (British Journal of Pharmacology)
• Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism (British Journal of Pharmacology)
• Cannabinoids for pediatric epilepsy (Division of Pediatric Neurology, University of Utah School of Medicine)
• Cannabinoids in the Treatment of Epilepsy (The New England Journal of Medicine)
• Cannabis, Cannabinoids and Tinnitus (Journal of Pharmacology and Drug Metabolism)
• CBD-enriched medical cannabis for intractable pediatric epilepsy The current Israeli experience (ScienceDirect)
• Epidiolex (Cannabidiol) in Treatment Resistant Epilepsy (Nationwide Children’s Hospital)
• Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity (European Journal of Pharmacology)
• On the application of cannabis in paediatrics and epileptology (Neuroendocrinology Letters)
• Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy (PLOS)
• Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy (National Institute of Health)
• The case for assessing cannabidiol in epilepsy (Epilepsia)
• The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy (The American Society for Pharmacology and Experimental Therapeutics)
• Understanding Cannabinoids and Epilepsy (Brain Treatment Center of Atlanta)